Human genetic variation and yellow fever mortality during 19th century U.S. epidemics

mBio

Volumn 5, Issue 3, 2014, Pages

  Blake, Lauren E ^a,b   Garcia Blancoa, Mariano A ^a,b,c  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ADULT; ARTICLE; BLACK PERSON; CAUCASIAN; CULTURAL FACTOR; DEMOGRAPHY; DISEASE SEVERITY; EPIDEMIC; ETHNIC DIFFERENCE; FATALITY; FEMALE; GENE LOCUS; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIOECONOMICS; UNITED STATES; YELLOW FEVER; GENETIC PREDISPOSITION; GENETICS; HISTORY; IMMUNOLOGY; INCIDENCE; RISK FACTOR; YELLOW FEVER VIRUS;

DISEASE OUTBREAKS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HISTORY, 19TH CENTURY; HUMANS; INCIDENCE; MORTALITY; RISK FACTORS; UNITED STATES; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 84903973614     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01253-14     Document Type: Article

References (31)

1. López C, Saravia C, Gomez A, Hoebeke J, Patarroyo MA. 2010. Mechanisms of genetically-based resistance to malaria. Gene 467: 1-12. http://dx. doi. org/10. 1016/j. gene. 2010. 07. 008.
2. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722-725. http://dx. doi. org/10. 1038/382722a0.
3. County, Shelby TN Census. 1870. Data from population schedules of the ninth census of the United States for Shelby County, Tennessee. http://tnroots. com/tnshelby/census/1870/.
4. Gardner CL, Ryman KD. 2010. Yellow fever: a reemerging threat. Clin. Lab. Med. 30: 237-260. http://dx. doi. org/10. 1016/j. cll. 2010. 01. 001.
5. Kanakaratne N, Wahala WM, Messer WB, Tissera HA, Shahani A, Abeysinghe N, de-Silva AM, Gunasekera M. 2009. Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg. Infect. Dis. 15: 192-199. http://dx. doi. org/10. 3201/eid1502. 080926.
6. Devignot S, Sapet C, Duong V, Bergon A, Rihet P, Ong S, Lorn PT, Chroeung N, Ngeav S, Tolou HJ, Buchy P, Couissinier-Paris P. 2010. Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue. PLoS One 5: e11671. http://dx. doi. org/10. 1371/journal. pone. 0011671.
7. Whitehorn J, Chau TN, Nguyet NM, Kien DT, Quyen NT, Trung DT, Pang J, Wills B, Van Vinh Chau N, Farrar J, Hibberd ML, Khor CC, Simmons CP. 2013. Genetic variants of MICB and PLCE1 and associations with non-severe dengue. PLoS One 8: e59067. http://dx. doi. org/10. 1371/journal. pone. 0059067.
8. Garske T, Van Kerkhove MD, Yactayo S, Ronveaux O, Lewis RF, Staples JE, Perea W, Ferguson NM, with the YF Expert Committee. 2013. Yellow fever burden estimation: summary. World Health Organization, Geneva, Switzerland. http://www. who. int/csr/disease/yellowfev/YellowFeverBurdenEstimation_Summary2013. pdf.
9. Barrett AD, Higgs S. 2007. Yellow fever: a disease that has yet to be conquered. Annu. Rev. Entomol. 52: 209-229. http://dx. doi. org/10. 1146/annurev. ento. 52. 110405. 091454.
10. Kiple KL, Kiple VH. 1977. Black yellow fever immunities, innate and acquired, as revealed in the American South. Soc. Sci. Hist. 1: 419-436. http://dx. doi. org/10. 2307/1170791.
11. Kiple KF, King VH. 1981. Another dimension to the black diaspora: diet, disease and racism. Cambridge University Press, Cambridge, United Kingdom.
12. Monath TP, Nichols R, Archambault WT, Moore L, Marchesani R, Tian J, Shope RE, Thomas N, Schrader R, Furby D, Bedford P. 2002. Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial. Am. J. Trop. Med. Hyg. 66: 533-541.
13. Kiple KF. 2001. Response to Sheldon Watts, "Yellow fever immunities in West Africa and the Americas in the age of slavery and beyond: a reappraisal. " J. Soc. Hist. 34: 969-974. http://dx. doi. org/10. 1353/jsh. 2001. 0058.
14. Keith J. 2012. Fever season: the story of a terrifying epidemic and the people who saved a city. Bloomsbury Press, New York, NY.
15. US War Department, Surgeon General's Office, Woodward JJ. 1868. Report on epidemic cholera and yellow fever in the army of the United States: during the year 1867. U. S. Government Printing Office, Washington, DC.
16. Bell AMI. 2010. Mosquito soldiers: malaria, yellow fever, and the course of the American Civil War. Louisiana State University Press, Baton Rouge, LA.
17. Humphreys M. 1999. Yellow fever and the South. Johns Hopkins University Press, Baltimore, MD.
18. Strode GK (ed). 1951. Yellow fever. McGraw-Hill Book Company, New York, NY.
19. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401. http://dx. doi. org/10. 1038/nature08309.
20. Augustin G. 1909. History of yellow fever. Searcy & Pfaff, New Orleans, LA.
21. Patterson KD. 1992. Yellow fever epidemics and mortality in the United States, 1693-1905. Soc. Sci. Med. 34: 855-865. http://dx. doi. org/10. 1016/0277-9536(92)90255-O.
22. Knipe DM, et al. (ed). 2007. Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
23. Kemp GT. 1890. The microscopical, spectroscopical, and chemical analysis of black vomit as an aid to health officers in the differential diagnosis of yellow-fever and malarial fevers. Public Health Pap. Rep. 16: 246-252.
24. Monath TP. 1987. Yellow fever: a medically neglected disease. Report on a seminar. Rev. Infect. Dis. 9: 165-175. http://dx. doi. org/10. 1093/clinids/9. 1. 165.
25. US Census Office, Porter PR, Wright CD. 1897. Census reports. Eleventh census: 1890: Population. U. S. Government Printing Office, Washington, DC.
26. Portsmouth Relief Association. 1856. Report of the Portsmouth Relief Association to the contributors of the fund for the relief of Portsmouth, Virginia, during the prevalence of the yellow fever in that town in 1855. H. K. Ellyson's Steam Power Presses, Richmond, VA.
27. Baker TH. 1968. Yellowjack. The yellow fever epidemic of 1878 in Memphis, Tennessee. Bull. Hist. Med. 42: 241-264.
28. Cates GL. 1976. The St. Marys yellow fever epidemic of 1808: Georgia's first confrontation. J. Med. Assoc. Ga 65: 287-289.
29. Howard Association of Norfolk, Va. 1857. Report of the Howards Association of Norfolk, Va: to all contributors who gave their valuable aid in behalf of the sufferers from epidemic yellow fever during the summer of 1855. Inquirer Printing Office, Philadelphia, PA.
30. Keating JM, Howard Association. 1879. A history of the yellow fever. The yellow fever epidemic of 1878, in Memphis, Tenn., embracing a complete list of the dead, the names of the doctors and nurses employed, names of all who contributed money or means, and the names and history of the Howards, together with other data, and lists of the dead elsewhere. Howard Association of Memphis, Memphis, TN.
31. Simons M. 1878. Note on the epidemic of yellow fever at Port Royal in 1877. Transactions of the South Carolina Medical Association. 28: 9-47.